United States Central Nervous System Drugs Market Report 2017

United States Central Nervous System Drugs Market Report 2017

1 Central Nervous System Drugs Overview

1.1 Product Overview and Scope of Central Nervous System Drugs

1.2 Classification of Central Nervous System Drugs

1.2.1 Type I

1.2.2 Type II

1.3 Application of Central Nervous System Drugs

1.3.1 Application 1

1.3.2 Application 2

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Central Nervous System Drugs (2012-2022)

1.4.1 United States Central Nervous System Drugs Sales and Growth Rate (2012-2022)

1.4.2 United States Central Nervous System Drugs Revenue and Growth Rate (2012-2022)

2 United States Central Nervous System Drugs Competition by Manufacturers

2.1 United States Central Nervous System Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Central Nervous System Drugs Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Central Nervous System Drugs Average Price by Manufactures (2015 and 2016)

2.4 Central Nervous System Drugs Market Competitive Situation and Trends

2.4.1 Central Nervous System Drugs Market Concentration Rate

2.4.2 Central Nervous System Drugs Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Central Nervous System Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Central Nervous System Drugs Sales and Market Share by States (2012-2017)

3.2 United States Central Nervous System Drugs Revenue and Market Share by States (2012-2017)

3.3 United States Central Nervous System Drugs Price by States (2012-2017)

4 United States Central Nervous System Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Central Nervous System Drugs Sales and Market Share by Type (2012-2017)

4.2 United States Central Nervous System Drugs Revenue and Market Share by Type (2012-2017)

4.3 United States Central Nervous System Drugs Price by Type (2012-2017)

4.4 United States Central Nervous System Drugs Sales Growth Rate by Type (2012-2017)

5 United States Central Nervous System Drugs Sales (Volume) by Application (2012-2017)

5.1 United States Central Nervous System Drugs Sales and Market Share by Application (2012-2017)

5.2 United States Central Nervous System Drugs Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Central Nervous System Drugs Manufacturers Profiles/Analysis

6.1 Johnson & Johnson

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Central Nervous System Drugs Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Johnson & Johnson Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Pfizer

6.2.2 Central Nervous System Drugs Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Pfizer Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Novartis

6.3.2 Central Nervous System Drugs Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Novartis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Roche

6.4.2 Central Nervous System Drugs Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Roche Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Sanofi-Aventis

6.5.2 Central Nervous System Drugs Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Sanofi-Aventis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Merck

6.6.2 Central Nervous System Drugs Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Merck Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 GSK

6.7.2 Central Nervous System Drugs Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 GSK Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Bayer Schering

6.8.2 Central Nervous System Drugs Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Bayer Schering Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Bristol-Myers Squibb

6.9.2 Central Nervous System Drugs Product Type, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Bristol-Myers Squibb Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 AbbVie

6.10.2 Central Nervous System Drugs Product Type, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 AbbVie Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Eli Lilly

6.12 AstraZeneca

6.13 Takeda

6.14 Actavis

6.15 Teva

6.16 Biogen

6.17 Shire

7 Central Nervous System Drugs Manufacturing Cost Analysis

7.1 Central Nervous System Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Central Nervous System Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Central Nervous System Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Central Nervous System Drugs Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Central Nervous System Drugs Market Forecast (2017-2022)

11.1 United States Central Nervous System Drugs Sales, Revenue Forecast (2017-2022)

11.2 United States Central Nervous System Drugs Sales Forecast by Type (2017-2022)

11.3 United States Central Nervous System Drugs Sales Forecast by Application (2017-2022)

11.4 Central Nervous System Drugs Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Central Nervous System Drugs

Table Classification of Central Nervous System Drugs

Figure United States Sales Market Share of Central Nervous System Drugs by Type in 2015

Table Application of Central Nervous System Drugs

Figure United States Sales Market Share of Central Nervous System Drugs by Application in 2015

Figure United States Central Nervous System Drugs Sales and Growth Rate (2012-2022)

Figure United States Central Nervous System Drugs Revenue and Growth Rate (2012-2022)

Table United States Central Nervous System Drugs Sales of Key Manufacturers (2015 and 2016)

Table United States Central Nervous System Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Central Nervous System Drugs Sales Share by Manufacturers

Figure 2016 Central Nervous System Drugs Sales Share by Manufacturers

Table United States Central Nervous System Drugs Revenue by Manufacturers (2015 and 2016)

Table United States Central Nervous System Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Central Nervous System Drugs Revenue Share by Manufacturers

Table 2016 United States Central Nervous System Drugs Revenue Share by Manufacturers

Table United States Market Central Nervous System Drugs Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Central Nervous System Drugs Average Price of Key Manufacturers in 2015

Figure Central Nervous System Drugs Market Share of Top 3 Manufacturers

Figure Central Nervous System Drugs Market Share of Top 5 Manufacturers

Table United States Central Nervous System Drugs Sales by States (2012-2017)

Table United States Central Nervous System Drugs Sales Share by States (2012-2017)

Figure United States Central Nervous System Drugs Sales Market Share by States in 2015

Table United States Central Nervous System Drugs Revenue and Market Share by States (2012-2017)

Table United States Central Nervous System Drugs Revenue Share by States (2012-2017)

Figure Revenue Market Share of Central Nervous System Drugs by States (2012-2017)

Table United States Central Nervous System Drugs Price by States (2012-2017)

Table United States Central Nervous System Drugs Sales by Type (2012-2017)

Table United States Central Nervous System Drugs Sales Share by Type (2012-2017)

Figure United States Central Nervous System Drugs Sales Market Share by Type in 2015

Table United States Central Nervous System Drugs Revenue and Market Share by Type (2012-2017)

Table United States Central Nervous System Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Central Nervous System Drugs by Type (2012-2017)

Table United States Central Nervous System Drugs Price by Type (2012-2017)

Figure United States Central Nervous System Drugs Sales Growth Rate by Type (2012-2017)

Table United States Central Nervous System Drugs Sales by Application (2012-2017)

Table United States Central Nervous System Drugs Sales Market Share by Application (2012-2017)

Figure United States Central Nervous System Drugs Sales Market Share by Application in 2015

Table United States Central Nervous System Drugs Sales Growth Rate by Application (2012-2017)

Figure United States Central Nervous System Drugs Sales Growth Rate by Application (2012-2017)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Johnson & Johnson Central Nervous System Drugs Sales Market Share (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Pfizer Central Nervous System Drugs Sales Market Share (2012-2017)

Table Novartis Basic Information List

Table Novartis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novartis Central Nervous System Drugs Sales Market Share (2012-2017)

Table Roche Basic Information List

Table Roche Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Roche Central Nervous System Drugs Sales Market Share (2012-2017)

Table Sanofi-Aventis Basic Information List

Table Sanofi-Aventis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Sanofi-Aventis Central Nervous System Drugs Sales Market Share (2012-2017)

Table Merck Basic Information List

Table Merck Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Merck Central Nervous System Drugs Sales Market Share (2012-2017)

Table GSK Basic Information List

Table GSK Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table GSK Central Nervous System Drugs Sales Market Share (2012-2017)

Table Bayer Schering Basic Information List

Table Bayer Schering Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Bayer Schering Central Nervous System Drugs Sales Market Share (2012-2017)

Table Bristol-Myers Squibb Basic Information List

Table Bristol-Myers Squibb Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Bristol-Myers Squibb Central Nervous System Drugs Sales Market Share (2012-2017)

Table AbbVie Basic Information List

Table AbbVie Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table AbbVie Central Nervous System Drugs Sales Market Share (2012-2017)

Table Eli Lilly Basic Information List

Table AstraZeneca Basic Information List

Table Takeda Basic Information List

Table Actavis Basic Information List

Table Teva Basic Information List

Table Biogen Basic Information List

Table Shire Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Central Nervous System Drugs

Figure Manufacturing Process Analysis of Central Nervous System Drugs

Figure Central Nervous System Drugs Industrial Chain Analysis

Table Raw Materials Sources of Central Nervous System Drugs Major Manufacturers in 2015

Table Major Buyers of Central Nervous System Drugs

Table Distributors/Traders List

Figure United States Central Nervous System Drugs Production and Growth Rate Forecast (2017-2022)

Figure United States Central Nervous System Drugs Revenue and Growth Rate Forecast (2017-2022)

Table United States Central Nervous System Drugs Production Forecast by Type (2017-2022)

Table United States Central Nervous System Drugs Consumption Forecast by Application (2017-2022)

Table United States Central Nervous System Drugs Sales Forecast by States (2017-2022)

Table United States Central Nervous System Drugs Sales Share Forecast by States (2017-2022)